nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB2A—hematologic cancer	0.283	1	CbGaD
Ixabepilone—TUBB2B—Vinorelbine—hematologic cancer	0.0241	0.0501	CbGbCtD
Ixabepilone—TUBB8—Vinorelbine—hematologic cancer	0.0241	0.0501	CbGbCtD
Ixabepilone—TUBB6—Vinorelbine—hematologic cancer	0.0241	0.0501	CbGbCtD
Ixabepilone—TUBB2A—Vinorelbine—hematologic cancer	0.0241	0.0501	CbGbCtD
Ixabepilone—TUBB3—Vinorelbine—hematologic cancer	0.0241	0.0501	CbGbCtD
Ixabepilone—TUBB4A—Vinorelbine—hematologic cancer	0.0241	0.0501	CbGbCtD
Ixabepilone—TUBB—Vinorelbine—hematologic cancer	0.0201	0.0419	CbGbCtD
Ixabepilone—TUBB1—Vinorelbine—hematologic cancer	0.0201	0.0419	CbGbCtD
Ixabepilone—TUBB4B—Vinorelbine—hematologic cancer	0.0201	0.0419	CbGbCtD
Ixabepilone—TUBB8—Vinblastine—hematologic cancer	0.0148	0.0309	CbGbCtD
Ixabepilone—TUBB6—Vinblastine—hematologic cancer	0.0148	0.0309	CbGbCtD
Ixabepilone—TUBB2B—Vinblastine—hematologic cancer	0.0148	0.0309	CbGbCtD
Ixabepilone—TUBB4A—Vinblastine—hematologic cancer	0.0148	0.0309	CbGbCtD
Ixabepilone—TUBB3—Vinblastine—hematologic cancer	0.0148	0.0309	CbGbCtD
Ixabepilone—TUBB2A—Vinblastine—hematologic cancer	0.0148	0.0309	CbGbCtD
Ixabepilone—TUBB4A—Vincristine—hematologic cancer	0.0146	0.0303	CbGbCtD
Ixabepilone—TUBB2B—Vincristine—hematologic cancer	0.0146	0.0303	CbGbCtD
Ixabepilone—TUBB3—Vincristine—hematologic cancer	0.0146	0.0303	CbGbCtD
Ixabepilone—TUBB2A—Vincristine—hematologic cancer	0.0146	0.0303	CbGbCtD
Ixabepilone—TUBB8—Vincristine—hematologic cancer	0.0146	0.0303	CbGbCtD
Ixabepilone—TUBB6—Vincristine—hematologic cancer	0.0146	0.0303	CbGbCtD
Ixabepilone—TUBB1—Vinblastine—hematologic cancer	0.0124	0.0258	CbGbCtD
Ixabepilone—TUBB4B—Vinblastine—hematologic cancer	0.0124	0.0258	CbGbCtD
Ixabepilone—TUBB—Vinblastine—hematologic cancer	0.0124	0.0258	CbGbCtD
Ixabepilone—TUBB1—Vincristine—hematologic cancer	0.0122	0.0254	CbGbCtD
Ixabepilone—TUBB4B—Vincristine—hematologic cancer	0.0122	0.0254	CbGbCtD
Ixabepilone—TUBB—Vincristine—hematologic cancer	0.0122	0.0254	CbGbCtD
Ixabepilone—CYP3A4—Bexarotene—hematologic cancer	0.00212	0.00441	CbGbCtD
Ixabepilone—CYP3A4—Lomustine—hematologic cancer	0.00197	0.0041	CbGbCtD
Ixabepilone—CYP3A4—Busulfan—hematologic cancer	0.00197	0.0041	CbGbCtD
Ixabepilone—CYP3A4—Thiotepa—hematologic cancer	0.00176	0.00366	CbGbCtD
Ixabepilone—TUBB3—hematopoietic system—hematologic cancer	0.00166	0.0531	CbGeAlD
Ixabepilone—TUBB1—hematopoietic system—hematologic cancer	0.00162	0.0519	CbGeAlD
Ixabepilone—CYP3A4—Methoxsalen—hematologic cancer	0.00137	0.00284	CbGbCtD
Ixabepilone—TUBB8—testis—hematologic cancer	0.00133	0.0426	CbGeAlD
Ixabepilone—CYP3A4—Bortezomib—hematologic cancer	0.0013	0.00271	CbGbCtD
Ixabepilone—CYP3A4—Daunorubicin—hematologic cancer	0.00124	0.00259	CbGbCtD
Ixabepilone—TUBB3—blood—hematologic cancer	0.0011	0.0352	CbGeAlD
Ixabepilone—CYP3A4—Cytarabine—hematologic cancer	0.0011	0.00228	CbGbCtD
Ixabepilone—CYP3A4—Teniposide—hematologic cancer	0.00108	0.00225	CbGbCtD
Ixabepilone—TUBB1—blood—hematologic cancer	0.00108	0.0344	CbGeAlD
Ixabepilone—TUBB1—bone marrow—hematologic cancer	0.00104	0.0333	CbGeAlD
Ixabepilone—TUBB4A—hematopoietic system—hematologic cancer	0.00101	0.0323	CbGeAlD
Ixabepilone—CYP3A4—Ifosfamide—hematologic cancer	0.000998	0.00207	CbGbCtD
Ixabepilone—TUBB3—lung—hematologic cancer	0.000964	0.0308	CbGeAlD
Ixabepilone—CYP3A4—Imatinib—hematologic cancer	0.000953	0.00198	CbGbCtD
Ixabepilone—TUBB2A—hematopoietic system—hematologic cancer	0.000919	0.0294	CbGeAlD
Ixabepilone—TUBB3—testis—hematologic cancer	0.000909	0.0291	CbGeAlD
Ixabepilone—TUBB6—hematopoietic system—hematologic cancer	0.000906	0.029	CbGeAlD
Ixabepilone—CYP3A4—Ruxolitinib—hematologic cancer	0.000897	0.00187	CbGbCtD
Ixabepilone—TUBB1—testis—hematologic cancer	0.000889	0.0285	CbGeAlD
Ixabepilone—CYP3A4—Nilotinib—hematologic cancer	0.000866	0.0018	CbGbCtD
Ixabepilone—CYP3A4—Vinorelbine—hematologic cancer	0.000859	0.00179	CbGbCtD
Ixabepilone—TUBB4B—hematopoietic system—hematologic cancer	0.000788	0.0252	CbGeAlD
Ixabepilone—CYP3A4—Triamcinolone—hematologic cancer	0.000785	0.00163	CbGbCtD
Ixabepilone—TUBB4A—gonad—hematologic cancer	0.000768	0.0246	CbGeAlD
Ixabepilone—CYP3A4—Dasatinib—hematologic cancer	0.000765	0.00159	CbGbCtD
Ixabepilone—CYP3A4—Mitoxantrone—hematologic cancer	0.000756	0.00157	CbGbCtD
Ixabepilone—TUBB2B—gonad—hematologic cancer	0.000742	0.0237	CbGeAlD
Ixabepilone—TUBB6—gonad—hematologic cancer	0.000689	0.022	CbGeAlD
Ixabepilone—CYP3A4—Betamethasone—hematologic cancer	0.000674	0.0014	CbGbCtD
Ixabepilone—TUBB4A—blood—hematologic cancer	0.000669	0.0214	CbGeAlD
Ixabepilone—CYP3A4—Prednisolone—hematologic cancer	0.000665	0.00138	CbGbCtD
Ixabepilone—CYP3A4—Prednisone—hematologic cancer	0.000628	0.00131	CbGbCtD
Ixabepilone—TUBB—blood—hematologic cancer	0.000612	0.0196	CbGeAlD
Ixabepilone—TUBB2A—blood—hematologic cancer	0.000609	0.0195	CbGeAlD
Ixabepilone—TUBB6—blood—hematologic cancer	0.0006	0.0192	CbGeAlD
Ixabepilone—TUBB4B—gonad—hematologic cancer	0.000599	0.0192	CbGeAlD
Ixabepilone—CYP3A4—Irinotecan—hematologic cancer	0.000595	0.00124	CbGbCtD
Ixabepilone—TUBB—bone marrow—hematologic cancer	0.000592	0.0189	CbGeAlD
Ixabepilone—TUBB2A—bone marrow—hematologic cancer	0.000589	0.0188	CbGeAlD
Ixabepilone—TUBB4A—lung—hematologic cancer	0.000587	0.0188	CbGeAlD
Ixabepilone—TUBB6—bone marrow—hematologic cancer	0.000581	0.0186	CbGeAlD
Ixabepilone—TUBB2B—lung—hematologic cancer	0.000567	0.0181	CbGeAlD
Ixabepilone—TUBB4A—testis—hematologic cancer	0.000553	0.0177	CbGeAlD
Ixabepilone—TUBB—lung—hematologic cancer	0.000536	0.0172	CbGeAlD
Ixabepilone—TUBB2B—testis—hematologic cancer	0.000535	0.0171	CbGeAlD
Ixabepilone—TUBB2A—lung—hematologic cancer	0.000534	0.0171	CbGeAlD
Ixabepilone—CYP3A4—Vinblastine—hematologic cancer	0.000529	0.0011	CbGbCtD
Ixabepilone—TUBB6—lung—hematologic cancer	0.000526	0.0168	CbGeAlD
Ixabepilone—TUBB4B—blood—hematologic cancer	0.000522	0.0167	CbGeAlD
Ixabepilone—CYP3A4—Vincristine—hematologic cancer	0.00052	0.00108	CbGbCtD
Ixabepilone—TUBB—testis—hematologic cancer	0.000506	0.0162	CbGeAlD
Ixabepilone—TUBB4B—bone marrow—hematologic cancer	0.000505	0.0162	CbGeAlD
Ixabepilone—TUBB2A—testis—hematologic cancer	0.000504	0.0161	CbGeAlD
Ixabepilone—TUBB6—testis—hematologic cancer	0.000497	0.0159	CbGeAlD
Ixabepilone—CYP3A4—Etoposide—hematologic cancer	0.000477	0.000992	CbGbCtD
Ixabepilone—TUBB4B—lung—hematologic cancer	0.000458	0.0146	CbGeAlD
Ixabepilone—TUBB4B—testis—hematologic cancer	0.000432	0.0138	CbGeAlD
Ixabepilone—TUBB4A—lymph node—hematologic cancer	0.000401	0.0128	CbGeAlD
Ixabepilone—CYP3A4—Dexamethasone—hematologic cancer	0.000392	0.000815	CbGbCtD
Ixabepilone—TUBB2B—lymph node—hematologic cancer	0.000388	0.0124	CbGeAlD
Ixabepilone—TUBB—lymph node—hematologic cancer	0.000367	0.0117	CbGeAlD
Ixabepilone—TUBB2A—lymph node—hematologic cancer	0.000365	0.0117	CbGeAlD
Ixabepilone—TUBB6—lymph node—hematologic cancer	0.00036	0.0115	CbGeAlD
Ixabepilone—CYP3A4—Doxorubicin—hematologic cancer	0.000325	0.000676	CbGbCtD
Ixabepilone—CYP3A4—hematopoietic system—hematologic cancer	0.000324	0.0104	CbGeAlD
Ixabepilone—TUBB4B—lymph node—hematologic cancer	0.000313	0.01	CbGeAlD
Ixabepilone—TUBB—Menadione—Thalidomide—hematologic cancer	0.000262	0.127	CbGdCrCtD
Ixabepilone—CYP3A4—blood—hematologic cancer	0.000214	0.00686	CbGeAlD
Ixabepilone—TUBB6—Vitamin A—Alitretinoin—hematologic cancer	0.000205	0.099	CbGdCrCtD
Ixabepilone—TUBB6—Zalcitabine—Gemcitabine—hematologic cancer	0.000163	0.0787	CbGdCrCtD
Ixabepilone—TUBB6—Zalcitabine—Cytarabine—hematologic cancer	0.000163	0.0787	CbGdCrCtD
Ixabepilone—TUBB6—Tretinoin—Alitretinoin—hematologic cancer	0.000143	0.0692	CbGdCrCtD
Ixabepilone—TUBB6—Isotretinoin—Alitretinoin—hematologic cancer	0.000143	0.0692	CbGdCrCtD
Ixabepilone—TUBB—Azacitidine—Pentostatin—hematologic cancer	0.000134	0.0649	CbGdCrCtD
Ixabepilone—TUBB—Azacitidine—Clofarabine—hematologic cancer	0.00012	0.0578	CbGdCrCtD
Ixabepilone—TUBB—Azacitidine—Nelarabine—hematologic cancer	0.000113	0.0543	CbGdCrCtD
Ixabepilone—TUBB—Azacitidine—Fludarabine—hematologic cancer	8.79e-05	0.0424	CbGdCrCtD
Ixabepilone—TUBB—Azacitidine—Cytarabine—hematologic cancer	8.3e-05	0.0401	CbGdCrCtD
Ixabepilone—TUBB—Azacitidine—Gemcitabine—hematologic cancer	8.3e-05	0.0401	CbGdCrCtD
Ixabepilone—TUBB—Azacitidine—Cladribine—hematologic cancer	8.09e-05	0.039	CbGdCrCtD
Ixabepilone—TUBB6—Azacitidine—Pentostatin—hematologic cancer	5.55e-05	0.0268	CbGdCrCtD
Ixabepilone—TUBB6—Azacitidine—Clofarabine—hematologic cancer	4.95e-05	0.0239	CbGdCrCtD
Ixabepilone—TUBB6—Azacitidine—Nelarabine—hematologic cancer	4.65e-05	0.0224	CbGdCrCtD
Ixabepilone—TUBB6—Azacitidine—Fludarabine—hematologic cancer	3.63e-05	0.0175	CbGdCrCtD
Ixabepilone—TUBB6—Azacitidine—Cytarabine—hematologic cancer	3.43e-05	0.0165	CbGdCrCtD
Ixabepilone—TUBB6—Azacitidine—Gemcitabine—hematologic cancer	3.43e-05	0.0165	CbGdCrCtD
Ixabepilone—TUBB6—Azacitidine—Cladribine—hematologic cancer	3.34e-05	0.0161	CbGdCrCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2e-05	0.000332	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—SPHK1—hematologic cancer	2e-05	0.000331	CbGpPWpGaD
Ixabepilone—TUBB4B—G2/M Transition—EP300—hematologic cancer	1.99e-05	0.00033	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—TOP2A—hematologic cancer	1.99e-05	0.00033	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.99e-05	0.000329	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—H3F3A—hematologic cancer	1.97e-05	0.000326	CbGpPWpGaD
Ixabepilone—TUBB4B—Mitotic G2-G2/M phases—EP300—hematologic cancer	1.97e-05	0.000326	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—SMC1A—hematologic cancer	1.97e-05	0.000325	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—HSP90AA1—hematologic cancer	1.96e-05	0.000324	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—RPS14—hematologic cancer	1.96e-05	0.000324	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—EIF4EBP1—hematologic cancer	1.95e-05	0.000323	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TOP2A—hematologic cancer	1.95e-05	0.000322	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.94e-05	0.000321	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—HSPA5—hematologic cancer	1.93e-05	0.000319	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—HSPA5—hematologic cancer	1.93e-05	0.000319	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—H3F3A—hematologic cancer	1.93e-05	0.000319	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—EIF4EBP1—hematologic cancer	1.91e-05	0.000316	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.88e-05	0.000312	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	1.88e-05	0.000312	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND2—hematologic cancer	1.88e-05	0.000311	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MLH1—hematologic cancer	1.88e-05	0.000311	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.87e-05	0.00031	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CALR—hematologic cancer	1.87e-05	0.000309	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CALR—hematologic cancer	1.87e-05	0.000309	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—HSPA5—hematologic cancer	1.86e-05	0.000308	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDK6—hematologic cancer	1.85e-05	0.000306	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.83e-05	0.000303	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.82e-05	0.000302	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.82e-05	0.000302	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	1.82e-05	0.0003	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDK6—hematologic cancer	1.81e-05	0.0003	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—FBXW7—hematologic cancer	1.81e-05	0.000299	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—FBXW7—hematologic cancer	1.81e-05	0.000299	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CALR—hematologic cancer	1.8e-05	0.000299	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—HSPA5—hematologic cancer	1.8e-05	0.000299	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—SMC1A—hematologic cancer	1.8e-05	0.000298	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—RPS14—hematologic cancer	1.79e-05	0.000296	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	1.79e-05	0.000296	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.79e-05	0.000296	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TOP2A—hematologic cancer	1.78e-05	0.000295	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	1.76e-05	0.000292	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—HSPA5—hematologic cancer	1.76e-05	0.000292	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—H3F3A—hematologic cancer	1.76e-05	0.000292	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.76e-05	0.000292	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CALR—hematologic cancer	1.75e-05	0.000289	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—FBXW7—hematologic cancer	1.75e-05	0.000289	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND2—hematologic cancer	1.74e-05	0.000288	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—EIF4EBP1—hematologic cancer	1.71e-05	0.000283	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CALR—hematologic cancer	1.71e-05	0.000283	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.71e-05	0.000282	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—FBXW7—hematologic cancer	1.69e-05	0.00028	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN2B—hematologic cancer	1.68e-05	0.000279	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.67e-05	0.000276	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	1.66e-05	0.000275	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDK6—hematologic cancer	1.65e-05	0.000274	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—FBXW7—hematologic cancer	1.65e-05	0.000274	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.63e-05	0.00027	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—BIRC5—hematologic cancer	1.62e-05	0.000269	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—HSP90AA1—hematologic cancer	1.62e-05	0.000269	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND2—hematologic cancer	1.59e-05	0.000263	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—HSPA5—hematologic cancer	1.58e-05	0.000262	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—EIF4EBP1—hematologic cancer	1.57e-05	0.000259	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	1.56e-05	0.000258	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND2—hematologic cancer	1.56e-05	0.000258	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CALR—hematologic cancer	1.53e-05	0.000254	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.52e-05	0.000252	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.52e-05	0.000252	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.5e-05	0.000248	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDK2—hematologic cancer	1.49e-05	0.000247	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—HSP90AA1—hematologic cancer	1.48e-05	0.000246	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—FBXW7—hematologic cancer	1.48e-05	0.000246	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.47e-05	0.000243	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—BIRC5—hematologic cancer	1.45e-05	0.00024	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—HSPA5—hematologic cancer	1.45e-05	0.00024	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	1.43e-05	0.000236	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.42e-05	0.000236	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND2—hematologic cancer	1.42e-05	0.000236	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.41e-05	0.000233	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TERT—hematologic cancer	1.41e-05	0.000233	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CALR—hematologic cancer	1.4e-05	0.000232	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2B—hematologic cancer	1.39e-05	0.000231	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.39e-05	0.00023	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.37e-05	0.000227	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—FBXW7—hematologic cancer	1.36e-05	0.000225	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—BIRC5—hematologic cancer	1.35e-05	0.000223	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDK2—hematologic cancer	1.33e-05	0.000221	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2B—hematologic cancer	1.28e-05	0.000211	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—ATM—hematologic cancer	1.26e-05	0.000209	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDK4—hematologic cancer	1.26e-05	0.000208	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.25e-05	0.000207	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDK2—hematologic cancer	1.23e-05	0.000204	CbGpPWpGaD
Ixabepilone—Headache—Mitoxantrone—hematologic cancer	1.23e-05	8.64e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—BIRC5—hematologic cancer	1.23e-05	0.000204	CbGpPWpGaD
Ixabepilone—Nausea—Ifosfamide—hematologic cancer	1.23e-05	8.62e-05	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.23e-05	8.6e-05	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.23e-05	8.6e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—RB1—hematologic cancer	1.22e-05	0.000203	CbGpPWpGaD
Ixabepilone—Arthralgia—Prednisone—hematologic cancer	1.22e-05	8.57e-05	CcSEcCtD
Ixabepilone—Myalgia—Prednisone—hematologic cancer	1.22e-05	8.57e-05	CcSEcCtD
Ixabepilone—Diarrhoea—Cisplatin—hematologic cancer	1.22e-05	8.56e-05	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—hematologic cancer	1.22e-05	8.55e-05	CcSEcCtD
Ixabepilone—Alopecia—Methotrexate—hematologic cancer	1.22e-05	8.54e-05	CcSEcCtD
Ixabepilone—Vomiting—Gemcitabine—hematologic cancer	1.22e-05	8.54e-05	CcSEcCtD
Ixabepilone—Insomnia—Dexamethasone—hematologic cancer	1.22e-05	8.53e-05	CcSEcCtD
Ixabepilone—Insomnia—Betamethasone—hematologic cancer	1.22e-05	8.53e-05	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.21e-05	8.51e-05	CcSEcCtD
Ixabepilone—Paraesthesia—Dexamethasone—hematologic cancer	1.21e-05	8.47e-05	CcSEcCtD
Ixabepilone—Paraesthesia—Betamethasone—hematologic cancer	1.21e-05	8.47e-05	CcSEcCtD
Ixabepilone—Mental disorder—Methotrexate—hematologic cancer	1.21e-05	8.47e-05	CcSEcCtD
Ixabepilone—Rash—Gemcitabine—hematologic cancer	1.21e-05	8.47e-05	CcSEcCtD
Ixabepilone—Dermatitis—Gemcitabine—hematologic cancer	1.21e-05	8.46e-05	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—hematologic cancer	1.21e-05	8.45e-05	CcSEcCtD
Ixabepilone—Hypersensitivity—Etoposide—hematologic cancer	1.2e-05	8.45e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—BIRC5—hematologic cancer	1.2e-05	0.000199	CbGpPWpGaD
Ixabepilone—Malnutrition—Methotrexate—hematologic cancer	1.2e-05	8.41e-05	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—hematologic cancer	1.2e-05	8.41e-05	CcSEcCtD
Ixabepilone—Headache—Gemcitabine—hematologic cancer	1.2e-05	8.41e-05	CcSEcCtD
Ixabepilone—Nausea—Vincristine—hematologic cancer	1.2e-05	8.41e-05	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—hematologic cancer	1.2e-05	8.4e-05	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—hematologic cancer	1.19e-05	8.37e-05	CcSEcCtD
Ixabepilone—Hypersensitivity—Prednisolone—hematologic cancer	1.19e-05	8.33e-05	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—hematologic cancer	1.19e-05	8.33e-05	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—hematologic cancer	1.18e-05	8.27e-05	CcSEcCtD
Ixabepilone—Asthenia—Etoposide—hematologic cancer	1.17e-05	8.23e-05	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—hematologic cancer	1.17e-05	8.23e-05	CcSEcCtD
Ixabepilone—Body temperature increased—Triamcinolone—hematologic cancer	1.17e-05	8.22e-05	CcSEcCtD
Ixabepilone—Oedema—Prednisone—hematologic cancer	1.17e-05	8.22e-05	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—hematologic cancer	1.17e-05	8.21e-05	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—hematologic cancer	1.17e-05	8.21e-05	CcSEcCtD
Ixabepilone—Decreased appetite—Dexamethasone—hematologic cancer	1.17e-05	8.2e-05	CcSEcCtD
Ixabepilone—Decreased appetite—Betamethasone—hematologic cancer	1.17e-05	8.2e-05	CcSEcCtD
Ixabepilone—Nausea—Mitoxantrone—hematologic cancer	1.17e-05	8.19e-05	CcSEcCtD
Ixabepilone—Nausea—Irinotecan—hematologic cancer	1.17e-05	8.19e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.17e-05	0.000193	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TERT—hematologic cancer	1.17e-05	0.000193	CbGpPWpGaD
Ixabepilone—Immune system disorder—Epirubicin—hematologic cancer	1.17e-05	8.17e-05	CcSEcCtD
Ixabepilone—Infection—Prednisone—hematologic cancer	1.16e-05	8.16e-05	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—hematologic cancer	1.16e-05	8.15e-05	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.16e-05	8.15e-05	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.16e-05	8.15e-05	CcSEcCtD
Ixabepilone—Fatigue—Betamethasone—hematologic cancer	1.16e-05	8.14e-05	CcSEcCtD
Ixabepilone—Fatigue—Dexamethasone—hematologic cancer	1.16e-05	8.14e-05	CcSEcCtD
Ixabepilone—Chills—Epirubicin—hematologic cancer	1.16e-05	8.12e-05	CcSEcCtD
Ixabepilone—Pruritus—Etoposide—hematologic cancer	1.16e-05	8.11e-05	CcSEcCtD
Ixabepilone—Shock—Prednisone—hematologic cancer	1.15e-05	8.08e-05	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	1.15e-05	0.000191	CbGpPWpGaD
Ixabepilone—Pain—Betamethasone—hematologic cancer	1.15e-05	8.07e-05	CcSEcCtD
Ixabepilone—Pain—Dexamethasone—hematologic cancer	1.15e-05	8.07e-05	CcSEcCtD
Ixabepilone—Nervous system disorder—Prednisone—hematologic cancer	1.15e-05	8.06e-05	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.14e-05	0.000189	CbGpPWpGaD
Ixabepilone—Alopecia—Epirubicin—hematologic cancer	1.14e-05	7.99e-05	CcSEcCtD
Ixabepilone—Skin disorder—Prednisone—hematologic cancer	1.14e-05	7.98e-05	CcSEcCtD
Ixabepilone—Nausea—Gemcitabine—hematologic cancer	1.14e-05	7.98e-05	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	1.14e-05	0.000188	CbGpPWpGaD
Ixabepilone—Vomiting—Cisplatin—hematologic cancer	1.13e-05	7.96e-05	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—hematologic cancer	1.13e-05	7.93e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDK2—hematologic cancer	1.13e-05	0.000187	CbGpPWpGaD
Ixabepilone—Erythema multiforme—Doxorubicin—hematologic cancer	1.13e-05	7.91e-05	CcSEcCtD
Ixabepilone—Rash—Cisplatin—hematologic cancer	1.13e-05	7.89e-05	CcSEcCtD
Ixabepilone—Dermatitis—Cisplatin—hematologic cancer	1.12e-05	7.88e-05	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—hematologic cancer	1.12e-05	7.87e-05	CcSEcCtD
Ixabepilone—Diarrhoea—Etoposide—hematologic cancer	1.12e-05	7.84e-05	CcSEcCtD
Ixabepilone—Anorexia—Prednisone—hematologic cancer	1.12e-05	7.83e-05	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—hematologic cancer	1.12e-05	7.82e-05	CcSEcCtD
Ixabepilone—Anaemia—Methotrexate—hematologic cancer	1.11e-05	7.78e-05	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—hematologic cancer	1.11e-05	7.77e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CDK2—hematologic cancer	1.1e-05	0.000183	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—BIRC5—hematologic cancer	1.1e-05	0.000182	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Betamethasone—hematologic cancer	1.1e-05	7.72e-05	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.1e-05	7.72e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—RB1—hematologic cancer	1.1e-05	0.000181	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Triamcinolone—hematologic cancer	1.09e-05	7.66e-05	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	1.08e-05	0.000179	CbGpPWpGaD
Ixabepilone—Angiopathy—Doxorubicin—hematologic cancer	1.08e-05	7.59e-05	CcSEcCtD
Ixabepilone—Dizziness—Etoposide—hematologic cancer	1.08e-05	7.58e-05	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—hematologic cancer	1.08e-05	7.57e-05	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—hematologic cancer	1.08e-05	7.56e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	1.08e-05	0.000178	CbGpPWpGaD
Ixabepilone—Mediastinal disorder—Doxorubicin—hematologic cancer	1.08e-05	7.54e-05	CcSEcCtD
Ixabepilone—Leukopenia—Methotrexate—hematologic cancer	1.07e-05	7.53e-05	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—hematologic cancer	1.07e-05	7.51e-05	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.07e-05	0.000177	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.07e-05	7.49e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.07e-05	0.000177	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TERT—hematologic cancer	1.07e-05	0.000177	CbGpPWpGaD
Ixabepilone—Dizziness—Prednisolone—hematologic cancer	1.07e-05	7.48e-05	CcSEcCtD
Ixabepilone—Asthenia—Triamcinolone—hematologic cancer	1.06e-05	7.46e-05	CcSEcCtD
Ixabepilone—Body temperature increased—Betamethasone—hematologic cancer	1.06e-05	7.46e-05	CcSEcCtD
Ixabepilone—Abdominal pain—Betamethasone—hematologic cancer	1.06e-05	7.46e-05	CcSEcCtD
Ixabepilone—Abdominal pain—Dexamethasone—hematologic cancer	1.06e-05	7.46e-05	CcSEcCtD
Ixabepilone—Body temperature increased—Dexamethasone—hematologic cancer	1.06e-05	7.46e-05	CcSEcCtD
Ixabepilone—Nausea—Cisplatin—hematologic cancer	1.06e-05	7.43e-05	CcSEcCtD
Ixabepilone—Insomnia—Prednisone—hematologic cancer	1.06e-05	7.43e-05	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—hematologic cancer	1.05e-05	7.4e-05	CcSEcCtD
Ixabepilone—Paraesthesia—Prednisone—hematologic cancer	1.05e-05	7.38e-05	CcSEcCtD
Ixabepilone—Pruritus—Triamcinolone—hematologic cancer	1.05e-05	7.36e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—ATM—hematologic cancer	1.05e-05	0.000173	CbGpPWpGaD
Ixabepilone—Cough—Methotrexate—hematologic cancer	1.05e-05	7.34e-05	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—hematologic cancer	1.05e-05	7.33e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CDK4—hematologic cancer	1.04e-05	0.000173	CbGpPWpGaD
Ixabepilone—Vomiting—Etoposide—hematologic cancer	1.04e-05	7.29e-05	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—hematologic cancer	1.04e-05	7.29e-05	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—hematologic cancer	1.04e-05	7.28e-05	CcSEcCtD
Ixabepilone—Rash—Etoposide—hematologic cancer	1.03e-05	7.23e-05	CcSEcCtD
Ixabepilone—Dermatitis—Etoposide—hematologic cancer	1.03e-05	7.22e-05	CcSEcCtD
Ixabepilone—Headache—Etoposide—hematologic cancer	1.02e-05	7.18e-05	CcSEcCtD
Ixabepilone—Arthralgia—Methotrexate—hematologic cancer	1.02e-05	7.16e-05	CcSEcCtD
Ixabepilone—Myalgia—Methotrexate—hematologic cancer	1.02e-05	7.16e-05	CcSEcCtD
Ixabepilone—Chest pain—Methotrexate—hematologic cancer	1.02e-05	7.16e-05	CcSEcCtD
Ixabepilone—Decreased appetite—Prednisone—hematologic cancer	1.02e-05	7.14e-05	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.02e-05	0.000168	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.02e-05	0.000168	CbGpPWpGaD
Ixabepilone—Rash—Prednisolone—hematologic cancer	1.02e-05	7.13e-05	CcSEcCtD
Ixabepilone—Dermatitis—Prednisolone—hematologic cancer	1.02e-05	7.12e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—RB1—hematologic cancer	1.01e-05	0.000168	CbGpPWpGaD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.01e-05	7.11e-05	CcSEcCtD
Ixabepilone—Fatigue—Prednisone—hematologic cancer	1.01e-05	7.08e-05	CcSEcCtD
Ixabepilone—Headache—Prednisolone—hematologic cancer	1.01e-05	7.08e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—CDK2—hematologic cancer	1.01e-05	0.000167	CbGpPWpGaD
Ixabepilone—Syncope—Epirubicin—hematologic cancer	1.01e-05	7.06e-05	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—hematologic cancer	1.01e-05	7.05e-05	CcSEcCtD
Ixabepilone—Constipation—Prednisone—hematologic cancer	1e-05	7.03e-05	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—hematologic cancer	9.99e-06	7.01e-05	CcSEcCtD
Ixabepilone—Loss of consciousness—Epirubicin—hematologic cancer	9.87e-06	6.92e-05	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.83e-06	0.000163	CbGpPWpGaD
Ixabepilone—Dizziness—Triamcinolone—hematologic cancer	9.81e-06	6.88e-05	CcSEcCtD
Ixabepilone—Cough—Epirubicin—hematologic cancer	9.8e-06	6.87e-05	CcSEcCtD
Ixabepilone—Infection—Methotrexate—hematologic cancer	9.73e-06	6.82e-05	CcSEcCtD
Ixabepilone—Nausea—Etoposide—hematologic cancer	9.71e-06	6.81e-05	CcSEcCtD
Ixabepilone—Asthenia—Betamethasone—hematologic cancer	9.65e-06	6.77e-05	CcSEcCtD
Ixabepilone—Asthenia—Dexamethasone—hematologic cancer	9.65e-06	6.77e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CDKN2A—hematologic cancer	9.63e-06	0.000159	CbGpPWpGaD
Ixabepilone—Nervous system disorder—Methotrexate—hematologic cancer	9.6e-06	6.73e-05	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—hematologic cancer	9.6e-06	6.73e-05	CcSEcCtD
Ixabepilone—Thrombocytopenia—Methotrexate—hematologic cancer	9.59e-06	6.72e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—ATM—hematologic cancer	9.59e-06	0.000159	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Prednisone—hematologic cancer	9.58e-06	6.72e-05	CcSEcCtD
Ixabepilone—Nausea—Prednisolone—hematologic cancer	9.58e-06	6.72e-05	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—hematologic cancer	9.56e-06	6.7e-05	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—hematologic cancer	9.56e-06	6.7e-05	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—hematologic cancer	9.56e-06	6.7e-05	CcSEcCtD
Ixabepilone—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	9.56e-06	0.000158	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDK4—hematologic cancer	9.55e-06	0.000158	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	9.54e-06	0.000158	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ALB—hematologic cancer	9.52e-06	0.000158	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ALB—hematologic cancer	9.52e-06	0.000158	CbGpPWpGaD
Ixabepilone—Pruritus—Dexamethasone—hematologic cancer	9.52e-06	6.68e-05	CcSEcCtD
Ixabepilone—Pruritus—Betamethasone—hematologic cancer	9.52e-06	6.68e-05	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.52e-06	0.000158	CbGpPWpGaD
Ixabepilone—Skin disorder—Methotrexate—hematologic cancer	9.51e-06	6.67e-05	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	9.49e-06	6.66e-05	CcSEcCtD
Ixabepilone—Vomiting—Triamcinolone—hematologic cancer	9.43e-06	6.61e-05	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—MTR—hematologic cancer	9.39e-06	0.000155	CbGpPWpGaD
Ixabepilone—Rash—Triamcinolone—hematologic cancer	9.35e-06	6.56e-05	CcSEcCtD
Ixabepilone—Dermatitis—Triamcinolone—hematologic cancer	9.34e-06	6.55e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—MDM2—hematologic cancer	9.34e-06	0.000155	CbGpPWpGaD
Ixabepilone—Anorexia—Methotrexate—hematologic cancer	9.34e-06	6.55e-05	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—hematologic cancer	9.32e-06	6.53e-05	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.31e-06	0.000154	CbGpPWpGaD
Ixabepilone—Leukopenia—Doxorubicin—hematologic cancer	9.3e-06	6.52e-05	CcSEcCtD
Ixabepilone—Headache—Triamcinolone—hematologic cancer	9.29e-06	6.51e-05	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—CCL2—hematologic cancer	9.29e-06	0.000154	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CCL2—hematologic cancer	9.29e-06	0.000154	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—RB1—hematologic cancer	9.28e-06	0.000154	CbGpPWpGaD
Ixabepilone—Body temperature increased—Prednisone—hematologic cancer	9.26e-06	6.5e-05	CcSEcCtD
Ixabepilone—Abdominal pain—Prednisone—hematologic cancer	9.26e-06	6.5e-05	CcSEcCtD
Ixabepilone—Diarrhoea—Betamethasone—hematologic cancer	9.21e-06	6.46e-05	CcSEcCtD
Ixabepilone—Diarrhoea—Dexamethasone—hematologic cancer	9.21e-06	6.46e-05	CcSEcCtD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ALB—hematologic cancer	9.2e-06	0.000152	CbGpPWpGaD
Ixabepilone—Oedema—Epirubicin—hematologic cancer	9.17e-06	6.43e-05	CcSEcCtD
Ixabepilone—Hypotension—Methotrexate—hematologic cancer	9.15e-06	6.42e-05	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—hematologic cancer	9.13e-06	6.4e-05	CcSEcCtD
Ixabepilone—Infection—Epirubicin—hematologic cancer	9.11e-06	6.38e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—hematologic cancer	9.1e-06	0.000151	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—RB1—hematologic cancer	9.07e-06	0.00015	CbGpPWpGaD
Ixabepilone—Cough—Doxorubicin—hematologic cancer	9.07e-06	6.36e-05	CcSEcCtD
Ixabepilone—Shock—Epirubicin—hematologic cancer	9.02e-06	6.32e-05	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—hematologic cancer	8.99e-06	6.3e-05	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—hematologic cancer	8.97e-06	6.29e-05	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—CCL2—hematologic cancer	8.97e-06	0.000148	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	8.94e-06	0.000148	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.92e-06	6.26e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	8.92e-06	0.000148	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ALB—hematologic cancer	8.91e-06	0.000147	CbGpPWpGaD
Ixabepilone—Skin disorder—Epirubicin—hematologic cancer	8.9e-06	6.24e-05	CcSEcCtD
Ixabepilone—Dizziness—Betamethasone—hematologic cancer	8.9e-06	6.24e-05	CcSEcCtD
Ixabepilone—Dizziness—Dexamethasone—hematologic cancer	8.9e-06	6.24e-05	CcSEcCtD
Ixabepilone—Insomnia—Methotrexate—hematologic cancer	8.86e-06	6.21e-05	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—hematologic cancer	8.85e-06	6.2e-05	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—hematologic cancer	8.85e-06	6.2e-05	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—hematologic cancer	8.85e-06	6.2e-05	CcSEcCtD
Ixabepilone—Nausea—Triamcinolone—hematologic cancer	8.81e-06	6.18e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	8.8e-06	0.000146	CbGpPWpGaD
Ixabepilone—Paraesthesia—Methotrexate—hematologic cancer	8.79e-06	6.17e-05	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	8.79e-06	6.16e-05	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—hematologic cancer	8.74e-06	6.13e-05	CcSEcCtD
Ixabepilone—Dyspnoea—Methotrexate—hematologic cancer	8.73e-06	6.12e-05	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.71e-06	0.000144	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CCL2—hematologic cancer	8.69e-06	0.000144	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Prednisone—hematologic cancer	8.63e-06	6.05e-05	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—hematologic cancer	8.56e-06	6.01e-05	CcSEcCtD
Ixabepilone—Vomiting—Dexamethasone—hematologic cancer	8.56e-06	6e-05	CcSEcCtD
Ixabepilone—Vomiting—Betamethasone—hematologic cancer	8.56e-06	6e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—CDKN1B—hematologic cancer	8.53e-06	0.000141	CbGpPWpGaD
Ixabepilone—Decreased appetite—Methotrexate—hematologic cancer	8.51e-06	5.97e-05	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—CCL2—hematologic cancer	8.49e-06	0.000141	CbGpPWpGaD
Ixabepilone—Rash—Betamethasone—hematologic cancer	8.48e-06	5.95e-05	CcSEcCtD
Ixabepilone—Rash—Dexamethasone—hematologic cancer	8.48e-06	5.95e-05	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—hematologic cancer	8.48e-06	5.95e-05	CcSEcCtD
Ixabepilone—Dermatitis—Dexamethasone—hematologic cancer	8.48e-06	5.94e-05	CcSEcCtD
Ixabepilone—Dermatitis—Betamethasone—hematologic cancer	8.48e-06	5.94e-05	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.46e-06	5.93e-05	CcSEcCtD
Ixabepilone—Fatigue—Methotrexate—hematologic cancer	8.44e-06	5.92e-05	CcSEcCtD
Ixabepilone—Headache—Betamethasone—hematologic cancer	8.43e-06	5.91e-05	CcSEcCtD
Ixabepilone—Headache—Dexamethasone—hematologic cancer	8.43e-06	5.91e-05	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—hematologic cancer	8.43e-06	5.91e-05	CcSEcCtD
Ixabepilone—Asthenia—Prednisone—hematologic cancer	8.41e-06	5.9e-05	CcSEcCtD
Ixabepilone—Pain—Methotrexate—hematologic cancer	8.38e-06	5.87e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—EP300—hematologic cancer	8.37e-06	0.000139	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.36e-06	0.000138	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.35e-06	5.86e-05	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—hematologic cancer	8.34e-06	5.85e-05	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—hematologic cancer	8.32e-06	5.83e-05	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—hematologic cancer	8.3e-06	5.82e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—RB1—hematologic cancer	8.3e-06	0.000137	CbGpPWpGaD
Ixabepilone—Pruritus—Prednisone—hematologic cancer	8.29e-06	5.81e-05	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—hematologic cancer	8.29e-06	5.81e-05	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—hematologic cancer	8.24e-06	5.78e-05	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—hematologic cancer	8.23e-06	5.77e-05	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—hematologic cancer	8.17e-06	5.73e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	8.16e-06	0.000135	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—hematologic cancer	8.13e-06	0.000135	CbGpPWpGaD
Ixabepilone—Anorexia—Doxorubicin—hematologic cancer	8.08e-06	5.67e-05	CcSEcCtD
Ixabepilone—Diarrhoea—Prednisone—hematologic cancer	8.02e-06	5.62e-05	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Methotrexate—hematologic cancer	8.01e-06	5.62e-05	CcSEcCtD
Ixabepilone—Nausea—Dexamethasone—hematologic cancer	7.99e-06	5.6e-05	CcSEcCtD
Ixabepilone—Nausea—Betamethasone—hematologic cancer	7.99e-06	5.6e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2A—hematologic cancer	7.98e-06	0.000132	CbGpPWpGaD
Ixabepilone—Decreased appetite—Epirubicin—hematologic cancer	7.97e-06	5.59e-05	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—hematologic cancer	7.92e-06	5.56e-05	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.91e-06	5.55e-05	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—hematologic cancer	7.9e-06	5.54e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	7.9e-06	0.000131	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1A—hematologic cancer	7.87e-06	0.00013	CbGpPWpGaD
Ixabepilone—Pain—Epirubicin—hematologic cancer	7.84e-06	5.5e-05	CcSEcCtD
Ixabepilone—Constipation—Epirubicin—hematologic cancer	7.84e-06	5.5e-05	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ALB—hematologic cancer	7.82e-06	0.000129	CbGpPWpGaD
Ixabepilone—Dizziness—Prednisone—hematologic cancer	7.75e-06	5.43e-05	CcSEcCtD
Ixabepilone—Abdominal pain—Methotrexate—hematologic cancer	7.74e-06	5.43e-05	CcSEcCtD
Ixabepilone—Body temperature increased—Methotrexate—hematologic cancer	7.74e-06	5.43e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—MDM2—hematologic cancer	7.74e-06	0.000128	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.73e-06	5.42e-05	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—hematologic cancer	7.67e-06	5.38e-05	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.64e-06	0.000126	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CCL2—hematologic cancer	7.63e-06	0.000126	CbGpPWpGaD
Ixabepilone—Paraesthesia—Doxorubicin—hematologic cancer	7.61e-06	5.34e-05	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—hematologic cancer	7.56e-06	5.3e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—hematologic cancer	7.54e-06	0.000125	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MAPK3—hematologic cancer	7.5e-06	0.000124	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Epirubicin—hematologic cancer	7.49e-06	5.26e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—EP300—hematologic cancer	7.49e-06	0.000124	CbGpPWpGaD
Ixabepilone—Vomiting—Prednisone—hematologic cancer	7.45e-06	5.22e-05	CcSEcCtD
Ixabepilone—Rash—Prednisone—hematologic cancer	7.39e-06	5.18e-05	CcSEcCtD
Ixabepilone—Dermatitis—Prednisone—hematologic cancer	7.38e-06	5.18e-05	CcSEcCtD
Ixabepilone—Decreased appetite—Doxorubicin—hematologic cancer	7.37e-06	5.17e-05	CcSEcCtD
Ixabepilone—Headache—Prednisone—hematologic cancer	7.34e-06	5.15e-05	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	7.32e-06	5.13e-05	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—hematologic cancer	7.31e-06	5.13e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—hematologic cancer	7.3e-06	0.000121	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2A—hematologic cancer	7.3e-06	0.000121	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	7.29e-06	0.000121	CbGpPWpGaD
Ixabepilone—Constipation—Doxorubicin—hematologic cancer	7.25e-06	5.09e-05	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—hematologic cancer	7.25e-06	5.09e-05	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—hematologic cancer	7.25e-06	5.08e-05	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—hematologic cancer	7.25e-06	5.08e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	7.23e-06	0.00012	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Methotrexate—hematologic cancer	7.22e-06	5.06e-05	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ALB—hematologic cancer	7.15e-06	0.000118	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MDM2—hematologic cancer	7.08e-06	0.000117	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1B—hematologic cancer	7.06e-06	0.000117	CbGpPWpGaD
Ixabepilone—Asthenia—Methotrexate—hematologic cancer	7.03e-06	4.93e-05	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—CCL2—hematologic cancer	6.98e-06	0.000115	CbGpPWpGaD
Ixabepilone—Nausea—Prednisone—hematologic cancer	6.96e-06	4.88e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—EP300—hematologic cancer	6.94e-06	0.000115	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.93e-06	4.86e-05	CcSEcCtD
Ixabepilone—Pruritus—Methotrexate—hematologic cancer	6.93e-06	4.86e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—hematologic cancer	6.89e-06	0.000114	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Epirubicin—hematologic cancer	6.75e-06	4.74e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—hematologic cancer	6.74e-06	0.000112	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MAPK3—hematologic cancer	6.71e-06	0.000111	CbGpPWpGaD
Ixabepilone—Body temperature increased—Doxorubicin—hematologic cancer	6.7e-06	4.7e-05	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—hematologic cancer	6.7e-06	4.7e-05	CcSEcCtD
Ixabepilone—Diarrhoea—Methotrexate—hematologic cancer	6.7e-06	4.7e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	6.67e-06	0.00011	CbGpPWpGaD
Ixabepilone—Asthenia—Epirubicin—hematologic cancer	6.58e-06	4.61e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—MYC—hematologic cancer	6.52e-06	0.000108	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1A—hematologic cancer	6.52e-06	0.000108	CbGpPWpGaD
Ixabepilone—Pruritus—Epirubicin—hematologic cancer	6.48e-06	4.55e-05	CcSEcCtD
Ixabepilone—Dizziness—Methotrexate—hematologic cancer	6.48e-06	4.54e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1B—hematologic cancer	6.46e-06	0.000107	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—EP300—hematologic cancer	6.35e-06	0.000105	CbGpPWpGaD
Ixabepilone—Diarrhoea—Epirubicin—hematologic cancer	6.27e-06	4.4e-05	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—hematologic cancer	6.25e-06	4.38e-05	CcSEcCtD
Ixabepilone—Vomiting—Methotrexate—hematologic cancer	6.23e-06	4.37e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	6.22e-06	0.000103	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—EP300—hematologic cancer	6.2e-06	0.000103	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	6.19e-06	0.000103	CbGpPWpGaD
Ixabepilone—Rash—Methotrexate—hematologic cancer	6.18e-06	4.33e-05	CcSEcCtD
Ixabepilone—Dermatitis—Methotrexate—hematologic cancer	6.17e-06	4.33e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—hematologic cancer	6.16e-06	0.000102	CbGpPWpGaD
Ixabepilone—Headache—Methotrexate—hematologic cancer	6.14e-06	4.3e-05	CcSEcCtD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	6.11e-06	0.000101	CbGpPWpGaD
Ixabepilone—Asthenia—Doxorubicin—hematologic cancer	6.08e-06	4.27e-05	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—hematologic cancer	6.06e-06	4.25e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—hematologic cancer	6.05e-06	0.0001	CbGpPWpGaD
Ixabepilone—Pruritus—Doxorubicin—hematologic cancer	6e-06	4.21e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1A—hematologic cancer	5.96e-06	9.87e-05	CbGpPWpGaD
Ixabepilone—Vomiting—Epirubicin—hematologic cancer	5.83e-06	4.09e-05	CcSEcCtD
Ixabepilone—Nausea—Methotrexate—hematologic cancer	5.82e-06	4.08e-05	CcSEcCtD
Ixabepilone—Diarrhoea—Doxorubicin—hematologic cancer	5.8e-06	4.07e-05	CcSEcCtD
Ixabepilone—Rash—Epirubicin—hematologic cancer	5.78e-06	4.05e-05	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—hematologic cancer	5.77e-06	4.05e-05	CcSEcCtD
Ixabepilone—Headache—Epirubicin—hematologic cancer	5.74e-06	4.03e-05	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	5.69e-06	9.42e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MAPK3—hematologic cancer	5.69e-06	9.41e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—EP300—hematologic cancer	5.67e-06	9.39e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	5.61e-06	9.29e-05	CbGpPWpGaD
Ixabepilone—Dizziness—Doxorubicin—hematologic cancer	5.61e-06	3.93e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—MAPK3—hematologic cancer	5.56e-06	9.2e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—hematologic cancer	5.53e-06	9.15e-05	CbGpPWpGaD
Ixabepilone—Nausea—Epirubicin—hematologic cancer	5.44e-06	3.82e-05	CcSEcCtD
Ixabepilone—TUBB4A—Cell Cycle—MYC—hematologic cancer	5.41e-06	8.95e-05	CbGpPWpGaD
Ixabepilone—Vomiting—Doxorubicin—hematologic cancer	5.39e-06	3.78e-05	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—TP53—hematologic cancer	5.36e-06	8.87e-05	CbGpPWpGaD
Ixabepilone—Rash—Doxorubicin—hematologic cancer	5.35e-06	3.75e-05	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—hematologic cancer	5.34e-06	3.75e-05	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—hematologic cancer	5.31e-06	3.73e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—MAPK3—hematologic cancer	5.08e-06	8.41e-05	CbGpPWpGaD
Ixabepilone—Nausea—Doxorubicin—hematologic cancer	5.04e-06	3.53e-05	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle—MYC—hematologic cancer	4.94e-06	8.18e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PHYH—hematologic cancer	4.75e-06	7.86e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—FTCD—hematologic cancer	4.75e-06	7.86e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GMPS—hematologic cancer	4.75e-06	7.86e-05	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—hematologic cancer	4.44e-06	7.35e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SMPD3—hematologic cancer	4.34e-06	7.18e-05	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—hematologic cancer	4.06e-06	6.72e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—DCK—hematologic cancer	3.79e-06	6.28e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	3.79e-06	6.28e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ASNS—hematologic cancer	3.79e-06	6.28e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HDC—hematologic cancer	3.6e-06	5.95e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CDA—hematologic cancer	3.29e-06	5.45e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PC—hematologic cancer	3.17e-06	5.24e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	3.06e-06	5.06e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GBA—hematologic cancer	3.06e-06	5.06e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTAP—hematologic cancer	2.8e-06	4.63e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—FHL2—hematologic cancer	2.49e-06	4.13e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AGRN—hematologic cancer	2.44e-06	4.05e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—IDH2—hematologic cancer	2.32e-06	3.84e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HMMR—hematologic cancer	2.32e-06	3.84e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.18e-06	3.61e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ACP5—hematologic cancer	2.12e-06	3.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CA9—hematologic cancer	2.12e-06	3.51e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.09e-06	3.46e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—IDH1—hematologic cancer	1.99e-06	3.3e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TXN—hematologic cancer	1.97e-06	3.26e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.97e-06	3.26e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.97e-06	3.26e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.93e-06	3.19e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.85e-06	3.07e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.8e-06	2.98e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.8e-06	2.98e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.76e-06	2.91e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NUP98—hematologic cancer	1.7e-06	2.82e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.65e-06	2.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.65e-06	2.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NUP214—hematologic cancer	1.64e-06	2.71e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTR—hematologic cancer	1.61e-06	2.66e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.61e-06	2.66e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ENO2—hematologic cancer	1.58e-06	2.61e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.53e-06	2.53e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—SDC1—hematologic cancer	1.49e-06	2.47e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NQO1—hematologic cancer	1.27e-06	2.1e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CD44—hematologic cancer	1.27e-06	2.1e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYCS—hematologic cancer	1.2e-06	1.99e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.19e-06	1.98e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.06e-06	1.75e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ABCB1—hematologic cancer	1e-06	1.66e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NCOR1—hematologic cancer	9.73e-07	1.61e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTM1—hematologic cancer	9.73e-07	1.61e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTHFR—hematologic cancer	8.6e-07	1.42e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	7.23e-07	1.2e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CREBBP—hematologic cancer	6.7e-07	1.11e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	6.35e-07	1.05e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALB—hematologic cancer	6.27e-07	1.04e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	6e-07	9.93e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.54e-07	9.17e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PTEN—hematologic cancer	4.79e-07	7.92e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—EP300—hematologic cancer	4.56e-07	7.55e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.38e-07	5.59e-06	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKT1—hematologic cancer	2.76e-07	4.56e-06	CbGpPWpGaD
